Ceska Gynekologie-Czech Gynaecology, ISSN 1210-7832, is a prominent journal in the field of obstetrics and gynecology, published by the esteemed NAKLADATELSKE STREDISKO C L S J E PURKYNE in the Czech Republic. Since its inception in 1959, this journal has served as a vital resource for researchers, practitioners, and students by disseminating high-quality research and insights pertinent to women's health. The journal is currently ranked in the Q3 category for Obstetrics and Gynecology, reflecting its respected position within the academic community, despite its Scopus ranking of #161 out of 209 in the medical field. Ceska Gynekologie offers a platform for sharing innovative clinical practices, research advancements, and educational resources, contributing significantly to the advancement of gynecological care. With a commitment to fostering professional knowledge and practice, this journal remains an essential tool for those engaged in the intricate world of women's health.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.

SEMINARS IN REPRODUCTIVE MEDICINE is a leading peer-reviewed journal dedicated to exploring the complexities of human reproduction, offering insightful perspectives that encompass advances in reproductive endocrinology, obstetrics, and gynecology. Published by THIEME MEDICAL PUBL INC, this esteemed journal holds a notable spot in multiple Scopus categories, ranking 21st in Reproductive Medicine and 38th in Obstetrics and Gynecology, with an impressive impact in the Q1 and Q2 quartiles. With its commitment to high-quality research and clinical implications, the journal serves as a vital resource for practitioners, researchers, and students alike, fostering an environment of innovation and collaboration in the rapidly evolving reproductive health landscape. SEMINARS IN REPRODUCTIVE MEDICINE also offers convenient open access options, ensuring that its contributions are readily available to the global academic community. For over two decades, from its establishment in 1999 to the present, it has retained a pivotal role in disseminating critical findings that inform both clinical practice and future research efforts.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed academic journal that has been providing critical insights and reviews in the fields of Obstetrics and Gynecology since its inception in 1989. With an ISSN of 1040-872X and an E-ISSN of 1473-656X, this journal plays a vital role in disseminating impactful research findings, clinical practices, and emerging trends in women's health. As a recognized entity in the medical community, it proudly ranks in the second quartile (Q2) across both Medicine (miscellaneous) and Obstetrics and Gynecology categories, underscoring its significance in shaping contemporary discourse. With an impressive Scopus ranking of #69 out of 209 in its field, it reflects a strong commitment to relevance and excellence in research. Although currently not offering open access, it remains a crucial platform for researchers, healthcare professionals, and students seeking to enhance their understanding and practice in obstetrics and gynecology. The journal’s ongoing evolution through to 2024 ensures that it will continue to be at the forefront of scientific advancement and clinical guidelines in women's health.

The International Journal of Endocrinology and Metabolism is a leading peer-reviewed publication dedicated to advancing knowledge and research in the fields of endocrinology, diabetes, and metabolism. Published by BRIEFLAND in the Netherlands, this journal features original research, comprehensive reviews, and insightful clinical studies that explore the multifaceted aspects of hormonal disorders and metabolic conditions. With an impact factor that places it in the Q3 quartile category for 2023, the journal serves as a critical resource for academics and practitioners aiming to stay at the forefront of this dynamic field. Spanning from 2010 to 2024, the journal offers an enriching platform for innovative ideas and practices, fostering collaboration among scholars and healthcare professionals alike. Although not open access, the content is meticulously curated to ensure high-quality scientific discourse, positioning the International Journal of Endocrinology and Metabolism as an essential reference for those dedicated to improving health outcomes related to endocrine and metabolic disorders.

Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Welcome to the Turkish Journal of Obstetrics and Gynecology, a premier publication dedicated to advancing the field of reproductive health and women's care. Published by GALENOS PUBL HOUSE since 2004, this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in obstetrics and gynecology. With an impact factor that reflects its growing influence, the journal is currently classified in the Q3 quartile within its category, ranking 114 out of 209 in Scopus, placing it in the 45th percentile. Offering a truly Open Access platform, it provides a global audience with immediate access to critical research findings. The journal encompasses a broad scope of topics aimed at improving health outcomes for women, with a focus on evidence-based practice. In recent years, from 2016 to 2024, it has significantly contributed to the regional and international discourse in the field, making it an invaluable resource for practitioners and scholars alike. Join us in exploring the vital issues and innovations shaping obstetrics and gynecology today.